Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study).
Nakasya A, Hagiwara Y, Ikoma T, Kurioka Y, Matsumoto T, Yamamoto Y, Tsuduki T, Kajiwara T, Moriwaki T, Nishina T, Yamashita N, Hyodo I. Nakasya A, et al. Among authors: hyodo i. Int J Clin Oncol. 2022 Apr;27(4):684-694. doi: 10.1007/s10147-022-02114-y. Epub 2022 Jan 28. Int J Clin Oncol. 2022. PMID: 35089459 Free PMC article.
Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).
Ohtsu A, Shimada Y, Shirao K, Boku N, Hyodo I, Saito H, Yamamichi N, Miyata Y, Ikeda N, Yamamoto S, Fukuda H, Yoshida S; Japan Clinical Oncology Group Study (JCOG9205). Ohtsu A, et al. Among authors: hyodo i. J Clin Oncol. 2003 Jan 1;21(1):54-9. doi: 10.1200/JCO.2003.04.130. J Clin Oncol. 2003. PMID: 12506170 Clinical Trial.
A Phase II study of irinotecan in combination with 120-h infusion of 5-fluorouracil in patients with metastatic colorectal carcinoma: Japan Clinical Oncology Group Study (JCOG9703).
Ohtsu A, Boku N, Yoshioka T, Hyodo I, Shirao K, Shimada Y, Saitoh S, Nakamura A, Yamamichi N, Yamamoto S, Yoshida S; Japan Clinical Oncology Group. Ohtsu A, et al. Among authors: hyodo i. Jpn J Clin Oncol. 2003 Jan;33(1):28-32. doi: 10.1093/jjco/hyg003. Jpn J Clin Oncol. 2003. PMID: 12604721 Clinical Trial.
[Clinical study of TS-1 therapy for inoperable and recurrent gastric cancer].
Moriwaki T, Hyodo I, Nishina T, Kajiwara T, Tsuzuki T, Hirao K, Nakauchi M, Nasu J, Hirasaki S, Endo H, Masumoto T, Tanimizu M, Kubo Y, Kurita A. Moriwaki T, et al. Among authors: hyodo i. Gan To Kagaku Ryoho. 2003 Apr;30(4):489-94. Gan To Kagaku Ryoho. 2003. PMID: 12722679 Japanese.
295 results